Back to News
Market Impact: 0.38

Rosenblatt raises 8x8 stock price target on strong Q4 results By Investing.com

EGHT
Corporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsCompany FundamentalsMarket Technicals & Flows
Rosenblatt raises 8x8 stock price target on strong Q4 results By Investing.com

8x8 reported Q4 fiscal 2026 revenue of $185.2 million and EPS of $0.11, both above consensus, while service revenue hit a record $180.2 million and operating margin reached 10.7%. Cash flow from operations was $14.4 million, marking the 21st straight quarter of positive cash flow, and Rosenblatt lifted its price target to $3.00 from $2.75 while keeping a Buy rating. The stock trades at $2.41, with the new target implying about 0.9x calendar 2027 sales versus a 1.7x peer average.

Analysis

The cleanest read-through is not just “beat-and-raise,” but that EGHT is now in the part of the cycle where operating leverage can compound faster than revenue growth. Once a software name exits a legacy drag and starts converting mid-single-digit growth into double-digit cash generation, the market often rerates on durability rather than trajectory, which is why the multiple gap versus peers matters more than the absolute target. The second-order effect is that every incremental proof point makes the turnaround harder to fade, because the bear case shifts from execution risk to “how much of the recovery is already priced.” What the market may be missing is that the stock likely trades as a functional call option on sentiment toward small-cap SaaS quality, not just company-specific fundamentals. If the next two quarters show continued gross margin/FCF stability, the name can attract generalist flows that are currently underexposed to sub-$5 software with positive cash flow, especially if rates remain steady and risk appetite broadens. But that same setup makes the stock vulnerable to any stumble: a single guide miss would likely compress the multiple faster than fundamentals would justify because expectations are moving up from a low base. The key catalyst window is the next earnings cycle, not the next few trading days. Near term, the stock can continue to grind higher on estimate revisions and momentum, but the real upside is contingent on management proving that the post-Fuze run-rate is not a one-quarter normalization event. The contrarian view is that the rerating could be partially exhausted if the market simply decides EGHT deserves a higher but still discounted multiple; in that case, upside becomes more about steady re-rating than explosive revaluation, and the risk/reward favors owning it only while expectations remain asymmetric.